Drawing for GLADIATOR FOR MEN

USPTO serial 98382414

GLADIATOR FOR MEN

Reviewed by CopyMark Law Group

Status 733Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
HALMEN, KATHERINE E
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 733: Status 733 means the fourth six-month extension was granted. Only one extension typically remains before you must file a Statement of Use or risk abandonment.

Need help with GLADIATOR FOR MEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $249*

Plus Government fees of $150

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Marc Baumgartner

2900 NW Clearwater Dr.Suite 200Bend, OR 97703

Goods and services

ClassDescriptionStatusFirst use
005Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of a coating for sublingual wafers that facilitate the delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of sublingual wafers that facilitate the delivery of pharmaceutical preparations; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for treating erectile dysfunction; Pharmaceutical preparations for inducing erections; Stem cells for medical purposes; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agentsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 10, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 9, 2026EX4GSOU EXTENSION 4 GRANTED—
Sep 4, 2026TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Sep 4, 2026NREVNOTICE OF REVIVAL - E-MAILED—
Sep 4, 2026PETGPETITION TO REVIVE-GRANTED—
Sep 4, 2026PROATEAS PETITION TO REVIVE RECEIVED—
Sep 3, 2026EXT4SOU EXTENSION 4 FILED—
Mar 4, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 3, 2026EX3GSOU EXTENSION 3 GRANTED—
Mar 3, 2026EXT3SOU EXTENSION 3 FILED—
Mar 3, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 15, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 3, 2025EX2GSOU EXTENSION 2 GRANTED—
Sep 3, 2025EXT2SOU EXTENSION 2 FILED—
Sep 3, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 16, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 15, 2025EX1GSOU EXTENSION 1 GRANTED—
May 12, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 4, 2025TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Mar 4, 2025NREVNOTICE OF REVIVAL - E-MAILED—
Mar 4, 2025PETGPETITION TO REVIVE-GRANTED—
Mar 4, 2025PROATEAS PETITION TO REVIVE RECEIVED—
Mar 2, 2025EXT1SOU EXTENSION 1 FILED—
Sep 3, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 9, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 9, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 19, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 4, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 4, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 4, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 4, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 3, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 3, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 3, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 30, 2024DOCKASSIGNED TO EXAMINER—
May 29, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 30, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance